vTv Therapeutics (VTVT) Competitors $13.53 -1.53 (-10.16%) Closing price 07/3/2025 02:15 PM EasternExtended Trading$14.07 +0.54 (+3.98%) As of 07/3/2025 04:25 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VTVT vs. CRGX, GNFT, PROK, DRUG, FDMT, KOD, ACIU, CTOR, CTMX, and EDITShould you be buying vTv Therapeutics stock or one of its competitors? The main competitors of vTv Therapeutics include CARGO Therapeutics (CRGX), GENFIT (GNFT), ProKidney (PROK), Bright Minds Biosciences (DRUG), 4D Molecular Therapeutics (FDMT), Kodiak Sciences (KOD), AC Immune (ACIU), Citius Oncology (CTOR), CytomX Therapeutics (CTMX), and Editas Medicine (EDIT). These companies are all part of the "pharmaceutical products" industry. vTv Therapeutics vs. Its Competitors CARGO Therapeutics GENFIT ProKidney Bright Minds Biosciences 4D Molecular Therapeutics Kodiak Sciences AC Immune Citius Oncology CytomX Therapeutics Editas Medicine vTv Therapeutics (NASDAQ:VTVT) and CARGO Therapeutics (NASDAQ:CRGX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, valuation, earnings, profitability, media sentiment, institutional ownership and dividends. Which has more volatility and risk, VTVT or CRGX? vTv Therapeutics has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500. Comparatively, CARGO Therapeutics has a beta of 0.28, suggesting that its share price is 72% less volatile than the S&P 500. Is VTVT or CRGX more profitable? CARGO Therapeutics' return on equity of -45.93% beat vTv Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets vTv TherapeuticsN/A -121.46% -46.75% CARGO Therapeutics N/A -45.93%-39.58% Do analysts rate VTVT or CRGX? vTv Therapeutics presently has a consensus price target of $35.50, indicating a potential upside of 162.38%. CARGO Therapeutics has a consensus price target of $15.00, indicating a potential upside of 235.57%. Given CARGO Therapeutics' higher probable upside, analysts plainly believe CARGO Therapeutics is more favorable than vTv Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score vTv Therapeutics 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00CARGO Therapeutics 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86 Which has higher earnings and valuation, VTVT or CRGX? vTv Therapeutics has higher revenue and earnings than CARGO Therapeutics. vTv Therapeutics is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiovTv Therapeutics$1.02M42.31-$18.46M-$3.01-4.50CARGO TherapeuticsN/AN/A-$167.50M-$4.62-0.97 Does the media favor VTVT or CRGX? In the previous week, vTv Therapeutics had 2 more articles in the media than CARGO Therapeutics. MarketBeat recorded 2 mentions for vTv Therapeutics and 0 mentions for CARGO Therapeutics. vTv Therapeutics' average media sentiment score of 0.20 beat CARGO Therapeutics' score of 0.00 indicating that vTv Therapeutics is being referred to more favorably in the media. Company Overall Sentiment vTv Therapeutics Neutral CARGO Therapeutics Neutral Do institutionals and insiders hold more shares of VTVT or CRGX? 17.5% of vTv Therapeutics shares are owned by institutional investors. Comparatively, 93.2% of CARGO Therapeutics shares are owned by institutional investors. 4.2% of vTv Therapeutics shares are owned by insiders. Comparatively, 2.9% of CARGO Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. SummaryvTv Therapeutics beats CARGO Therapeutics on 9 of the 14 factors compared between the two stocks. Get vTv Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for VTVT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VTVT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VTVT vs. The Competition Export to ExcelMetricvTv TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$48.11M$2.91B$5.53B$8.95BDividend YieldN/A2.42%5.38%4.09%P/E Ratio-4.5021.5627.4020.24Price / Sales42.31277.33417.66125.07Price / CashN/A41.9536.6357.47Price / Book3.027.518.085.67Net Income-$18.46M-$55.05M$3.16B$248.47M7 Day Performance-6.63%4.59%2.81%3.29%1 Month Performance-15.44%4.86%3.69%5.18%1 Year Performance-25.98%5.82%35.30%21.35% vTv Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VTVTvTv Therapeutics2.0727 of 5 stars$13.53-10.2%$35.50+162.4%-27.8%$48.11M$1.02M-4.509CRGXCARGO Therapeutics1.6844 of 5 stars$4.13-3.3%$15.00+263.2%-70.9%$196.89MN/A-0.89116GNFTGENFIT2.016 of 5 stars$3.81-3.1%$13.00+241.2%-4.0%$196.49M$76.77M0.00120Positive NewsGap UpPROKProKidney1.8465 of 5 stars$0.61-8.2%$4.50+642.6%-70.4%$193.21M$80K-1.013News CoverageGap UpHigh Trading VolumeDRUGBright Minds Biosciences3.1822 of 5 stars$27.09-0.8%$83.25+207.3%+2,544.9%$192.37MN/A-75.25N/ANews CoveragePositive NewsAnalyst ForecastGap UpFDMT4D Molecular Therapeutics2.3282 of 5 stars$3.77-8.7%$29.56+684.0%-80.4%$191.32M$40K-1.19120News CoverageAnalyst ForecastGap UpKODKodiak Sciences4.1612 of 5 stars$3.63+0.3%$9.00+147.9%+80.0%$191.01MN/A-1.0090Positive NewsACIUAC Immune2.6529 of 5 stars$1.83-2.7%$12.00+555.7%-45.9%$188.77M$31.02M-3.16140CTORCitius Oncology0.1792 of 5 stars$2.50-4.9%$3.00+20.0%N/A$188.18MN/A0.00N/AGap DownCTMXCytomX Therapeutics4.1564 of 5 stars$2.16-6.9%$5.33+146.9%+91.5%$187.04M$138.10M4.50170EDITEditas Medicine4.3875 of 5 stars$2.10-5.4%$4.70+123.8%-44.5%$185.84M$32.31M-0.69230Gap Up Related Companies and Tools Related Companies CRGX Alternatives GNFT Alternatives PROK Alternatives DRUG Alternatives FDMT Alternatives KOD Alternatives ACIU Alternatives CTOR Alternatives CTMX Alternatives EDIT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VTVT) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding vTv Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share vTv Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
